PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of bmccancBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Cancer
 
From:
Published online 2008 March 28. doi: 10.1186/1471-2407-8-82

Table 9

Survival in trials comparing gemcitabine to gemcitabine plus other cytotoxic agent

ReferenceYearTreatment regimenMedian survival (mo)PHR95% CI
Oettle2005Gemcitabine6.30.8480.980.82 – 1.18
Gemcitabine + Pemetrexed6.2
Rocha Lima2004Gemcitabine6.60.7891.040.84 – 1.30
Gemcitabine + Irinotecan6.3
Stathopoulos2006Gemcitabine6.50.970nana
Gemcitabine + Irinotecan6.4
O'Reilly2004Gemcitabine6.20.520.930.74 – 1.17
Gemcitabine + Exatecan6.7

na = data not available;